Non-hallucinogenic psychedelic psychotherapy: Decreasing risk and increasing access, or missing the point?
Journal of Psychedelic Studies May 27, 2024 Joanna Pashdag 1 citation
AbstractOver the past decade, numerous open-label studies and early clinical trials have shown that psychedelics hold promise for the fast and possibly lasting relief of a wide range of conditions ranging from major depressive disorder, end-of-life anxiety, and obsessive-compulsive disorder to smoking, alcohol use, and eating disorders. Among the questions still to be resolved in this endeavor...